Compare MIDD & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MIDD | PTCT |
|---|---|---|
| Founded | 1888 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.0B | 5.7B |
| IPO Year | 1995 | 2006 |
| Metric | MIDD | PTCT |
|---|---|---|
| Price | $167.40 | $78.04 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 17 |
| Target Price | ★ $180.13 | $80.65 |
| AVG Volume (30 Days) | 436.5K | ★ 1.4M |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 264.48 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,201,202,000.00 | $264,734,000.00 |
| Revenue This Year | $5.87 | N/A |
| Revenue Next Year | $3.22 | $17.70 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 36.19 |
| 52 Week Low | $110.82 | $43.18 |
| 52 Week High | $169.44 | $87.50 |
| Indicator | MIDD | PTCT |
|---|---|---|
| Relative Strength Index (RSI) | 67.08 | 63.46 |
| Support Level | $145.86 | $73.41 |
| Resistance Level | $168.32 | $79.67 |
| Average True Range (ATR) | 4.97 | 3.10 |
| MACD | 0.82 | 0.60 |
| Stochastic Oscillator | 78.33 | 93.63 |
The Middleby Corp is engaged in designing, manufacturing, marketing, distribution and service of a broad line of foodservice equipment used in all types of commercial restaurants and institutional kitchens, food preparation, cooking, baking, chilling and packaging equipment for food processing operations, and premium kitchen equipment including ranges, ovens, refrigerators, ventilation, dishwashers and outdoor cooking equipment used in the residential market. The company conducts its business through three principal business segments namely the Commercial Foodservice Equipment Group, the Food Processing Equipment Group and the Residential Kitchen Equipment Group. The firm derives majority revenue from Commercial Foodservice Equipment Group segment.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.